Four health care provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).
Magellan Health Services, Inc. (MGLN) ups its rating to a B (“buy”) this week after earning a C (“hold”) in the week before. Magellan Health Services coordinates and manages the delivery of behavioral healthcare treatment services. In Portfolio Grader’s specific subcategories of Earnings Surprise and Cash Flow, MGLN also gets A’s. The stock’s price of $60.83 is nearing the 52-week high of $62.00. Shares of the stock have been trading at an exceptionally rapid pace, up twofold from the week prior. For more information, get Portfolio Grader’s complete analysis of MGLN stock.
Cardinal Health, Inc. (CAH) is making headway this week, with the company’s rating improving to an A (“strong buy”) from a B (“buy”) last week. Cardinal Health provides products and services related to the safety and productivity of healthcare. Shares of CAH have increased 7.6% over the past month, better than the 1.7% decrease the S&P 500 has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of CAH stock.
Amedisys, Inc. (AMED) earns a B this week, jumping up from last week’s grade of C. Amedisys provides home health care and hospice services in the United States. Investors have pushed the stock price up 12.5% over the past month. For more information, get Portfolio Grader’s complete analysis of AMED stock.
This is a strong week for Concord Medical Services Holding Ltd. ADR (CCM). The company’s rating climbs to A from the previous week’s B. Concord Medical Services operates a network of radiotherapy and diagnostic imaging centers in the People’’s Republic of China. Wall Street seems to agree with the upgrade and has propelled the stock up 61.3% over the past month. For more information, get Portfolio Grader’s complete analysis of CCM stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
